Regulatory updates, compliance insights, and industry analysis from the ACPL team.
Recent searches reveal minimal NDPS notifications in Q1 2026, while related pharmaceutical regulations show active enforcement. Key compliance insights.
Read MoreCDSCO threatens rejection of 2+ year pending applications by Feb 14, 2026. New IVD import guidance and cosmetic enforcement actions…
Read More
Key highlights from the CDSCO circular on “Testing of drugs for grant of permissions for import/manufacture of New Drug for…
Read More
G.S.R. 135(E) – Changes to the Drugs Rules On February 16, 2026, the Central Drugs Standard Control Organization (CDSCO) rolled…
Read More
Let’s be real: in today’s business world, you can’t just ignore compliance. It’s not a box to tick—it’s something you’ve…
Read MoreHighlights and benefits of the recent U.S.–India trade agreement, with a focus on what it does (including tariff reductions) and…
Read MoreIndia-EU Free Trade Agreement — The “Mother of All Deals” Big news on the trade front: On January 27, 2026,…
Read More
Noida’s business scene is changing fast, and if you want your products to hit the market without hiccups, you need…
Read More
New Drug & Medical Device Registration in India: A Complete Guide for Businesses India’s healthcare and pharmaceutical market is booming.…
Read More